miR-133 has therapeutic application in heart disease as a key regulator of cardiac hypertrophy [72], a protective effect against myocardial ischemia-reperfusion (IR) injury in Sprague Dawley rats, [73] and improves cardiac function and fibrosis via inhibiting Akt in heart failure rats [74]. This evidence concerns the gene AKT1 and heart failure.